Atypical focal nodular hyperplasia of the liver: Imaging features of nonspecific and liver-specific MR contrast agents

American Journal of Roentgenology

Volumn 179, Issue 6, 2002, Pages 1447-1456

  Ba Ssalamah, Ahmed ^a   Schima, Wolfgang ^a   Schmook, Maria T ^a   Linnau, Ken F ^b   Schibany, Nadja ^a   Helbich, Thomas ^a   Reimer, Peter ^c   Laeng, Friedrich ^a   Wrba, Friedrich ^a   Kurtaran, Amir ^a   Ryan, Mark ^d   Mann, Frederick A ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Klinikum Karlsruhe   (Germany)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GADODIAMIDE; GADOLINIUM PENTETATE; MANGAFODIPIR; SUPERPARAMAGNETIC IRON OXIDE;

ADULT; APPARATUS; ARTICLE; AUSTRIA; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DRUG UPTAKE; ECHOGRAPHY; FEMALE; HEMANGIOMA; HUMAN; IMAGE ANALYSIS; IMAGE ENHANCEMENT; IMAGE QUALITY; LIVER HEMORRHAGE; LIVER HYPERPLASIA; LIVER METASTASIS; LIVER NECROSIS; LIVER PARENCHYMA; MALE; NODULAR HYPERPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; SIGNAL PROCESSING;

EID: 0036893134     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.179.6.1791447     Document Type: Article

References (31)

1. Nguyen BN, Flejou JF, Terris B, Belghiti J, Degott C. Focal nodular hyperplasia of the liver: A comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol 1999;23:1441-1454
2. Procacci C, Fugazzola C, Cinquino M, et al. Contribution of CT to characterization of focal nodular hyperplasia of the liver. Gastrointest Radiol 1992;17:63-73
3. Brancatelli G, Federle MP, Grazioli L, Blachar A, Peterson MS, Thaete L. Focal nodular hyperplasia: CT findings with emphasis on mulfiphasic helical CT in 78 patients. Radiology 2001;219:61-68
4. Mattison GR, Glazer GM, Quint LE, Francis IR, Bree RL, Ensminger WD. MR imaging of hepatic focal nodular hyperplasia: Characterization and distinction from primary malignant hepatic tumors. AJR 1987;148:711-715
5. Lee MJ, Saini S, Hamm B, et al. Focal nodular hyperplasia of the liver: MR findings in 35 proved cases. AJR 1991;156:317-320
6. Rummeny E, Weissleder R, Sironi S, et al. Central scars in primary liver tumors: MR features, specificity, and pathologic correlation. Radiology 1989;171:323-326
7. Grazioli L, Morana G, Federle MP. Focal nodular hyperplasia: Morphologic and functional information from MR imaging with gadobenate dimeglumine. Radiology 2001;221:731-739
8. Mathieu D, Rahmouni A, Anglade MC, et al. Focal nodular hyperplasia of the liver: Assessment with contrast-enhanced turboFLASH MR imaging. Radiology 1991;180:25-30
9. Semelka RC, Shoenut JP, Kroeker MA, et al. Focal liver disease: Comparison of dynamic contrast enhanced CT and T2-weighted fat-suppressed, FLASH, and dynamic gadolinium-enhanced MR imaging at 1.5 T. Radiology 1992;184:687-694
10. Mahfouz AE, Hamm B, Taupitz M, Wolf KJ. Hypervascular liver lesions: differentiation of focal nodular hyperplasia from malignant tumors with dynamic gadolinium-enhanced MR imaging. Radiology 1993;186:133-138
11. Marti-Bonmati L, Masid L, Torrijo C, Casillas C, Ferrer MD. Dynamic MR imaging of liver tumors: Analysis with temporal reconstruction images. Radiology 1994;193:677-682
12. Elizondo G, Fretz CJ, Stark DD, et al. Preclinical evaluation of MnDPDP: New paramagnetic hepatobiliary contrast agent for MR imaging. Radiology 1991;178:73-78
13. Nakayama M, Yamashita Y, Mitsuzaki K, et al. Improved tissue characterization of focal liver lesions with ferumoxide-enhanced T1 and T2-weighted MR imaging. J Magn Reson Imaging 2000;11:647-654
14. Grandin C, Van Beers BE, Robert A, Gigot JF, Geubel A, Pringot J. Benign hepatocellular tumors: MRI after superparamagnetic iron oxide administration. J Comput Assist Tomogr 1995;19:412-418
15. Beets-Tan RG, Van Engelshoven JM, Greve JW. Hepatic adenoma and focal nodular hyperplasia: MR findings with superparamagnetic iron oxide-enhanced MRI. Clin Imaging 1998;22:211-215
16. Ba-Ssalamah A, Heinz-Peer G, Schima W, et al. Detection of focal hepatic lesions: Comparison of unenhanced and SHU 555 A-enhanced MR imaging versus biphasic helical CTAP. J Magn Reson Imaging 2000;11:665-672
17. Precetti-Morel S, Bellin MF, Ghebontni L, et al. Focal nodular hyperplasia of the liver on ferumoxides-enhanced MR imaging: Features on conventional spin-echo, fast spin-echo and gradient-echo pulse sequences. Eur Radiol 1999;9:1535-1542
18. Vogl TJ, Hamm B, Schnell B, et al. Mn-DPDP enhancement patterns of hepatocellular lesions on MR images. J Magn Reson Imaging 1993;3:51-58
19. Coffin CM, Diche T, Mahfouz A, et al. Benign and malignant hepatocellular tumors: Evaluation of tumoral enhancement after mangafodipir trisodium injection on MR imaging. Eur Radiol 1999;9:444-449
20. Urhahn R, Klose KC, Drobnitzky M. Hepatic focal nodular hyperplasia: Diagnosis by ultrafast Gd-DTPA enhanced FLASH MR. J Comput Assist Tomogr 1991;15:848-851
21. Vilgrain V, Flejou J-F, Arrive L, et al. Focal nodular hyperplasia of the liver: MR imaging and pathologic correlation in 37 patients. Radiology 1992;184:699-703
22. Mathieu D, Paret M, Mahfouz AE, et al. Hyperintense benign liver lesions on spin-echo T1-weighted MR images: Pathologic correlations. Abdom Imaging 1997;22:410-417
23. Soyer P, Roche A, Levesque M, Legmann P. CT of fibrolamellar hepatocellular carcinoma. J Comput Assist Tomogr 1991;15:533-538
24. Nokes SR, Baker ME, Spritzer CE, Meyers W, Herfkens RJ. Hepatic adenoma: MR appearance mimicking focal nodular hyperplasia. J Comput Assist Tomogr 1988;12:885-887
25. Wilbur AC, Gyi B. Hepatocellular carcinoma: MR appearance mimicking focal nodular hyperplasia. AJR 1987;149:721-722
26. Vogl TJ, Hammerstingl R, Schwarz W, et al. Magnetic resonance imaging of focal liver lesions: Comparison of the superparamagnetic iron oxide Resovist versus gadolinium-DTPA in the same patient. Invest Radiol 1996;31:696-708
27. Weissleder R, Stark DD, Engelstad BL, et al. Superparamagnetic iron oxide: Pharmacokinetics and toxicity. AJR 1989;152:167-173
28. Boulahdour H, Cherqui D, Charlotte F, et al. The hot spot hepatobiliary scan in focal nodular hyperplasia. J Nucl Med 1993;34:2105-2110
29. Semelka RC, Helmberger TK. Contrast agents for MR imaging of the liver. Radiology 2001;218:27-38
30. Jones EC, Chezmar JL, Nelson RC, Bernardino ME. The frequency and significance of small (≤15 mm) hepatic lesions detected by CT. AJR 1992;158:535-539
31. Marlin DR, Semelka RC, Chung JJ, Balci NC, Wilber K. Sequential use of gadolinium chelate and mangafodipir trisodium for the assessment of focal liver lesions: Initial observations. Magn Reson Imaging 2000;18:955-963